ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,528Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 1454

$1.32M Total Retail Price of All Prescriptions

Rank: 33 out of 1454

668 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 668 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 668 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

4% of this provider’s 20,088 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
FUROSEMIDE 1,121 916 1 6
METOPROLOL TARTRATE 887 789 2 10
SIMVASTATIN 883 750 3 1
POTASSIUM CHLORIDE 780 686 4 15
DIGOXIN 560 506 5 70
AMLODIPINE BESYLATE 550 507 6 2
OMEPRAZOLE 485 425 7 3
METFORMIN HCL 484 382 8 8
LISINOPRIL 458 362 9 4
LEVOTHYROXINE SODIUM 418 358 10 5
DICLOFENAC SODIUM 373 315 11 118
HYDROCHLOROTHIAZIDE 344 281 12 9
NEXIUM 308 217 13 23
TRAMADOL HCL 308 246 13 20
HYDROCODONE-ACETAMINOPHEN 299 245 S3 15 7
GLYBURIDE 290 263 R 16 98
WARFARIN SODIUM 287 264 17 17
LOSARTAN POTASSIUM 283 267 18 14
NITROGLYCERIN PATCH 268 257 19 190
TRAMADOL HCL-ACETAMINOPHEN 265 228 20 165
TAMSULOSIN HCL 258 199 21 34
LANSOPRAZOLE 257 203 22 140
CLOPIDOGREL 253 233 23 32
SPIRONOLACTONE 252 201 24 63
GABAPENTIN 244 203 25 16
ALENDRONATE SODIUM 234 167 26 35
CIPROFLOXACIN HCL 195 169 27 64
RANITIDINE HCL 192 132 28 43
LANOXIN 191 191 29 242
ALLOPURINOL 182 171 30 28
LOSARTAN-HYDROCHLOROTHIAZIDE 177 165 31 38
ATENOLOL 177 150 31 18
DONEPEZIL HCL 176 176 33 29
METOPROLOL SUCCINATE 172 110 34 13
ADVAIR DISKUS 166 130 35 47
COMBIVENT 164 138 36 115
PLAVIX 163 154 37 45
CLONIDINE HCL 161 140 38 49
ZETIA 155 106 39 69
SERTRALINE HCL 149 106 40 26
THEOPHYLLINE ANHYDROUS 144 102 41 247
ATORVASTATIN CALCIUM 144 127 41 11
ZOLPIDEM TARTRATE 142 120 43 19
FINASTERIDE 142 117 43 94
TRICOR 137 97 45 134
FENOFIBRATE 131 102 46 68
CRESTOR 128 105 47 22
LOVASTATIN 125 111 48 39
JANUVIA 124 59 49 77
ACETAMINOPHEN-CODEINE 123 81 S3 50 179
GLIMEPIRIDE 120 87 51 33
ENALAPRIL MALEATE 119 96 52 58
ESCITALOPRAM OXALATE 116 106 53 78
PREDNISONE 112 102 54 36
ISOSORBIDE DINITRATE 112 106 54 254
NIFEDIPINE ER 107 97 56 102
ACTOS 105 104 57 90
AZITHROMYCIN 105 85 57 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 78 59 27
FLUTICASONE PROPIONATE 104 84 59 30
AMITRIPTYLINE HCL 104 79 R 59 71
ISOSORBIDE MONONITRATE ER 102 98 62 46
CEPHALEXIN 100 87 63 127
POLYETHYLENE GLYCOL 3350 98 87 64 61
CELEBREX 97 91 65 81
DIOVAN 97 86 65 40
PRAVASTATIN SODIUM 95 75 67 12
PRANDIN 93 93 68 296
HYDRALAZINE HCL 92 88 69 67
PHENYTOIN SODIUM EXTENDED 91 49 70 138
METOCLOPRAMIDE HCL 89 62 71 121
METOLAZONE 89 81 71 216
NITROSTAT 88 81 73 208
NAMENDA 86 86 74 48
CARVEDILOL 86 55 74 24
LANTUS 85 82 76 51
CYMBALTA 85 64 76 55
CARAFATE 84 68 78 322
DIPYRIDAMOLE 83 72 R 79 369
CITALOPRAM HBR 83 64 79 21
CILOSTAZOL 82 70 81 224
VERAPAMIL ER 81 81 82 89
SINGULAIR 80 57 83 83
PIOGLITAZONE HCL 79 75 R 84 235
PROPRANOLOL HCL 79 67 84 129
BENAZEPRIL HCL 78 69 86 57
COUMADIN 77 77 87 119
HYDROXYZINE HCL 77 64 R 87 183
PAROXETINE HCL 76 46 89 73
PROMETHAZINE HCL 76 54 R 89 82
EXELON 76 76 89 135
LYRICA 74 50 92 103
MECLIZINE HCL 73 60 93 132
TRIAMTERENE-HCTZ 73 71 93 44
AMLODIPINE BESYLATE-BENAZEPRIL 71 53 95 65
DIVALPROEX SODIUM 69 0 96 106
LANTUS SOLOSTAR 67 44 97 79
CEFUROXIME 66 56 98 150
GLIPIZIDE 64 49 99 62
EVISTA 63 63 100 136
LEVOXYL 60 46 101 84
CARISOPRODOL 60 44 R 101 123
INSULIN SYRINGE 60 46 101 97
FLUOXETINE HCL 59 20 104 72
CYCLOBENZAPRINE HCL 59 37 R 104 59
DILTIAZEM 24HR CD 57 47 106 76
DIPHENOXYLATE-ATROPINE 56 50 107 328
NIFEDIAC CC 56 33 107 246
PROAIR HFA 56 42 107 56
KLOR-CON 10 55 47 110 141
SYNTHROID 55 47 110 25
ACARBOSE 55 14 110 347
CAPTOPRIL 55 47 110 270
VYTORIN 54 46 114 170
NITROFURANTOIN 52 46 115 273
OXYCODONE-ACETAMINOPHEN 52 48 S2 115 60
DILTIAZEM ER 50 50 117 126
BISOPROLOL-HYDROCHLOROTHIAZIDE 50 50 117 124
AVODART 50 35 117 243
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 25, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.